Arvind Remedies (ARL) has received an approval for demerger of Irungattukottai unit of the company into their wholly owned subsidiary (WOS), Arvind Wellness and fixed the appointed date as April 08, 2013. The board of directors at its meeting held on May 15, 2013 has approved for the same. The resultant company (WOS) will be issuing preference share to the shareholders of ARL as a part of the demerger scheme.
For the above purpose, the board has authorized the Managing Director of the company to sign, execute and file necessary applications/ documents/ papers in matters relating to demerger to various statutory authorities including Stock Exchange, High Court etc.
Arvind Remedies is engaged in manufacturing of pharmaceutical formulations such as tablets, capsules (including soft gels), ointments and liquids. It has a manufacturing facility at Kakkalur in Tamil Nadu.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: